Literature DB >> 21068828

The environment and schizophrenia.

Jim van Os1, Gunter Kenis, Bart P F Rutten.   

Abstract

Psychotic syndromes can be understood as disorders of adaptation to social context. Although heritability is often emphasized, onset is associated with environmental factors such as early life adversity, growing up in an urban environment, minority group position and cannabis use, suggesting that exposure may have an impact on the developing 'social' brain during sensitive periods. Therefore heritability, as an index of genetic influence, may be of limited explanatory power unless viewed in the context of interaction with social effects. Longitudinal research is needed to uncover gene-environment interplay that determines how expression of vulnerability in the general population may give rise to more severe psychopathology.

Entities:  

Mesh:

Year:  2010        PMID: 21068828     DOI: 10.1038/nature09563

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Cannabis use and genetic predisposition for schizophrenia: a case-control study.

Authors:  W Veling; J P Mackenbach; J van Os; H W Hoek
Journal:  Psychol Med       Date:  2008-05-19       Impact factor: 7.723

2.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk.

Authors:  C B Pedersen; P B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2001-11

3.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

4.  Are extended twin family designs worth the trouble? A comparison of the bias, precision, and accuracy of parameters estimated in four twin family models.

Authors:  Matthew C Keller; Sarah E Medland; Laramie E Duncan
Journal:  Behav Genet       Date:  2009-12-16       Impact factor: 2.805

Review 5.  Epigenetic mediation of environmental influences in major psychotic disorders.

Authors:  Bart P F Rutten; Jonathan Mill
Journal:  Schizophr Bull       Date:  2009-09-25       Impact factor: 9.306

6.  Do theory of mind and executive function deficits underlie the adverse outcomes associated with profound early deprivation?: findings from the English and Romanian adoptees study.

Authors:  Emma Colvert; Michael Rutter; Jana Kreppner; Celia Beckett; Jenny Castle; Christine Groothues; Amanda Hawkins; Suzanne Stevens; Edmund J S Sonuga-Barke
Journal:  J Abnorm Child Psychol       Date:  2008-04-22

7.  Sources of individual differences in depressive symptoms: analysis of two samples of twins and their families.

Authors:  K S Kendler; E E Walters; K R Truett; A C Heath; M C Neale; N G Martin; L J Eaves
Journal:  Am J Psychiatry       Date:  1994-11       Impact factor: 18.112

8.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

Review 9.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

10.  The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.

Authors:  P D Morrison; V Zois; D A McKeown; T D Lee; D W Holt; J F Powell; S Kapur; R M Murray
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

View more
  429 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Stefania Maccari; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

3.  Introduction: The extended psychosis phenotype--relationship with schizophrenia and with ultrahigh risk status for psychosis.

Authors:  Jim van Os; Richard J Linscott
Journal:  Schizophr Bull       Date:  2012-03       Impact factor: 9.306

Review 4.  Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Authors:  Dragan M Svrakic; Patrick J Lustman; Ashok Mallya; Taylor Andrea Lynn; Rhonda Finney; Neda M Svrakic
Journal:  Mo Med       Date:  2012 Mar-Apr

Review 5.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 6.  Environmental influence in the brain, human welfare and mental health.

Authors:  Heike Tost; Frances A Champagne; Andreas Meyer-Lindenberg
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

7.  Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Authors:  Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

8.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

9.  Chronic treatment with the antipsychotic drug blonanserin modulates the responsiveness to acute stress with anatomical selectivity.

Authors:  Francesca Marchisella; Maria Serena Paladini; Alice Guidi; Veronica Begni; Paola Brivio; Vittoria Spero; Francesca Calabrese; Raffaella Molteni; Marco Andrea Riva
Journal:  Psychopharmacology (Berl)       Date:  2020-04-15       Impact factor: 4.530

10.  The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults.

Authors:  G C Nitzburg; A K Malhotra; P DeRosse
Journal:  Eur Psychiatry       Date:  2014-01-16       Impact factor: 5.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.